Literature DB >> 4161741

Hypercalcemia of thyrotoxicosis.

J D Baxter, P K Bondy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4161741     DOI: 10.7326/0003-4819-65-3-429

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  32 in total

1.  Nononcologic disease in patients with cancer.

Authors:  B B Lowitz; R S Benjamin
Journal:  West J Med       Date:  1977-07

2.  Thyrotoxic vomiting.

Authors: 
Journal:  Br Med J       Date:  1976-11-06

3.  Causes of anorexia in untreated hyperthyroidism: a prospective study.

Authors:  W X Dai; X W Meng
Journal:  Postgrad Med J       Date:  2000-05       Impact factor: 2.401

Review 4.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

5.  Treatment of thyrotoxicosis.

Authors:  R S Swerdloff
Journal:  Calif Med       Date:  1970-08

6.  Serum calcium and phosphate changes in thyroidectomized dogs.

Authors:  J Jowsey
Journal:  Calcif Tissue Res       Date:  1969

7.  Control of hypercalcaemia in thyrotoxicosis.

Authors:  M K Jones; S E Papapoulos
Journal:  Postgrad Med J       Date:  1979-12       Impact factor: 2.401

8.  Thyroxine-induced stimulation of hepatic cell transport of calcium and magnesium.

Authors:  S Wallach; J V Bellavia; P J Gamponia; P Bristrim
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

9.  Management of hyperparathyroid patients with grave hypercalcemia.

Authors:  L E Tisell; G Hedbäck; S Jansson; G Lindstedt; B F Zachrisson
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

10.  Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate.

Authors:  T T Tan; A A Alzaid; N Sutcliffe; M D Gardner; J A Thomson; I T Boyle
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.